Unravel
2 known investors
Unravel Bio uses patient RNA data and AI to build "Living Molecular Twins" of patients' biological networks, identifying new therapeutic mechanisms and clinically derisking them via the off-target effects of existing drugs. The platform targets rare and complex disorders (including Rett syndrome) and supports drug discovery for patients with such conditions.
AI & Machine LearningBiotechDigital Health
Investors · 2
Frequently asked questions
- What does Unravel do?
- Unravel Bio uses patient RNA data and AI to build "Living Molecular Twins" of patients' biological networks, identifying new therapeutic mechanisms and clinically derisking them via the off-target effects of existing drugs. The platform targets rare and complex disorders (including Rett syndrome) and supports drug discovery for patients with such conditions.
- Who are Unravel's investors?
- Unravel's investors include Beresford Ventures, BoxOne Ventures.